新2备用网址（www.hg108.vip）是一个开放新2网址即时比分、新2网址代理最新登录线路、新2网址会员最新登录线路、新2网址代理APP下载、新2网址会员APP下载、新2网址线路APP下载、新2网址电脑版下载、新2网址手机版下载的新2新现金网平台。新2网址登录线路最新、新2皇冠网址更新最快,皇冠体育APP开放皇冠会员注册、皇冠代理开户等业务。

PETALING JAYA: Malaysian Genomics Resource Centre Bhd (MGRC) has entered into a strategic partnership with Saudi Arabia-based United Doctors Hospital (UDH) for collaboration in genomics and cell therapies.

In a filing with Bursa Malaysia, the genomics and biopharmaceutical specialist said the partnership is valid for three years.

Under the partnership, MGRC and UDH will take the necessary steps to encourage and promote cooperation in the sales and marketing of genetic screening tests and cell therapy products; collaboration in research and development (R&D), and other areas of cooperation in genomics and cell therapies to be mutually decided by both parties.

新2代理网址（www.hg108.vip）实时更新发布最新最快最有效的新2网址和新2最新网址,包括新2手机网址,新2备用网址,皇冠最新网址,新2足球网址,新2网址大全。

UDH, located in Jeddah, Saudi Arabia, is accredited by the Saudi Central Board for Accreditation of Healthcare Institutions.

“This strategic partnership with UDH enables us to expand the geographical reach of our products and services beyond Malaysia to the Middle East and North Africa region.

“It will also enable us to collaborate on R&D with various domain specialists to enhance our suite of genetic screening tests and cell therapies,” executive director Azri Azerai said in a statement.